What is Coenzyme Q10
Lipid-soluble lipoquinone · essential component of mitochondrial electron transport chain · endogenous synthesis drops 50% with age + statin depletion.
Essential component of the electron transport chain · endogenous synthesis drops 50% post-60 years. Q-SYMBIO trial: −43% CV mortality in heart failure with 300 mg/day × 2 years. Critical in statin users (induced Q10 depletion up to 40%).
6Coenzyme Q10 appears in 6 protocols personalizable→Lipid-soluble lipoquinone · essential component of mitochondrial electron transport chain · endogenous synthesis drops 50% with age + statin depletion.
Coenzyme Q10 (CoQ10, ubiquinone) is a lipid-soluble lipoquinone present in ALL cells of the body, with maximum concentrations in high-energy-demand organs: heart, brain, liver, kidney. It's an essential cofactor of Complex I, II and III of the mitochondrial electron transport chain · without sufficient Q10, ATP production falls significantly.
Exists in two interconvertible forms: ubiquinone (oxidized form) and ubiquinol (reduced form). Ubiquinol is the biologically active form that captures free radicals + transfers electrons · young adults maintain 95% ubiquinol / 5% ubiquinone ratio · post-60 years the ratio inverts towards more ubiquinone (worse function).
Endogenous synthesis drops 50% post-60 years + is directly inhibited by statins (HMG-CoA reductase is also limiting step in Q10 synthesis). Chronic statin users may lose 30-40% of muscle Q10 · partially explains statin-induced myopathy.
5 pivotal studies · cardinal Q-SYMBIO trial in heart failure + CV events meta-analysis + statin-Q10.
| Study | Finding | Hallmarks |
|---|---|---|
Q-SYMBIO · CoQ10 in heart failure Mortensen et al · JACC Heart Fail 2014 | 2-year RCT · n=420 HF class III-IV · 300 mg/day CoQ10 vs placebo · −43% CV mortality, −42% MACE, −44% CV hospitalizations. NYHA class improvement. Effect independent of optimal pharmacotherapy. | CVMortality |
CoQ10 and statin-induced myopathy Mancuso et al · CNS Neurol Disord Drug Targets 2010 | Meta 7 RCTs · n=479 patients with statin-induced myalgia · 100-200 mg/day CoQ10 significantly reduced muscle pain and plasma CK vs placebo. Mechanism: reverse muscle Q10 depletion. | MuscleStatin |
Ubiquinol vs Ubiquinone · bioavailability Hosoe et al · Regul Toxicol Pharmacol 2007 | Crossover n=22 · 100 mg ubiquinol raises plasma Q10 1.8× faster and 2.0× higher than same ubiquinone dose · especially significant in elders 60+ (with less capacity to reduce ubiquinone→ubiquinol). | BioavailabilityAge |
CoQ10 + selenium · elderly mortality Alehagen et al · PLoS One 2015 | KiSel-10 RCT · n=443 elders 70-88 years · 4 years · 200 mg CoQ10 + 200 µg selenium: −53% CV mortality, cardiac function improvement on echocardio. Necessary combo (Q10 without Se doesn't work in Se-deficient). | MortalitySynergy |
Meta-analysis CoQ10 in hypertension Rosenfeldt et al · J Hum Hypertens 2007 | Meta 12 RCTs · n=362 hypertensives · 100-225 mg/d CoQ10 reduced systolic pressure 11 mmHg and diastolic 7 mmHg · effect independent of other antihypertensives. Mechanism: endothelial vasodilation + vascular muscle mitochondrial function. | HypertensionEndothelium |
My Protocol generates 3 personalized plans with exact form, dose and combos based on your profile. No commitment.
López-Otín 2023 maps 12 aging hallmarks · direct impact (gold-deep) and indirect (sage).
Protocol based on use · general cardio-protection 100-200 mg · clinical HF 300 mg · always with fatty meal.
For general mitochondrial support in young-middle adults with adequate endogenous synthesis. Take with dinner (highest fat meal of day). Ubiquinone (standard form) also works at <60 years.
Ubiquinol mandatory · capacity to reduce ubiquinone drops with age. Divide in 2 doses (100 mg breakfast + 100 mg dinner) for better plasma stability. Critical if you take statins.
Q-SYMBIO trial dose · only under cardiological supervision. Effects on NYHA class + mortality at 6-12 months. DOES NOT replace pharmacotherapy (ACEIs, beta-blockers, ARNI) · it's complementary.
Selenium mandatory cofactor (KiSel-10 trial 2015) · PQQ promotes mitochondrial biogenesis (Q10 loads existing + PQQ creates new). Complete pro-mitochondrial stack.
Chemical form is CRITICAL · ubiquinol superior in elders 60+ and statin users. KP/Kaneka® brand is the ubiquinol gold-standard.
Absolute criterion · look for «Kaneka KP®» or «Kaneka Ubiquinol» in ingredient list. It's natural fermentation ubiquinol · rest are inferior synthetic ubiquinol.
Dose: 100 mg Kaneka KP® ubiquinol/day
Form: Kaneka KP® ubiquinol · softgel with sunflower oil
Cert.: GMP · third-party tested · Kaneka authentic
Fillers: Sunflower oil + tocopherol antioxidant
Dose: 100 mg Kaneka KP® ubiquinol + 10 mg PQQ
Form: Ubiquinol + PQQ (mitochondrial biogenesis)
Cert.: GMP · Kaneka authentic
Fillers: Softgel with oil + non-GMO
Dose: 100 mg ubiquinone/day
Form: Standard ubiquinone (NOT ubiquinol)
Cert.: GMP · NSF
Fillers: Flax oil · natural vitamin E
My Protocol recommends form + brand + exact dose based on your age, budget and biomarkers. No commitment · 3 minutes.
3 biomarkers · one direct (plasma Q10), two indirect cardiovascular.
Plasma CoQ10. Direct marker · target >1.2 µg/mL (cardio-protective optimal range). Deficient <0.6 µg/mL. ~55 € in Spanish private analytics (Synlab · CTO). Useful pre/post supplementation to confirm absorption.
Cardiac function · echocardio. LVEF (left ventricular ejection fraction) in HF patients · improves ~3-7 points with CoQ10 at 6-12 months (Q-SYMBIO sub-analysis). Requires cardiological supervision.
Systolic blood pressure. Typical reduction 10 mmHg in hypertensives with elevated baseline (Rosenfeldt 2007 meta). Detectable change in 8-12 weeks with 200 mg/d ubiquinol.
Complete cardio-preventive · CoQ10 plasma + LVEF echocardio + advanced lipid profile + Lp(a) + apoB. Particularly recommended if you take chronic statins.
Excellent safety profile · few but significant interactions with anticoagulants and antihypertensives.
4 combos · CoQ10 is key puzzle piece of mitochondrial · combos amplify effect.
KiSel-10 trial · selenium mandatory cofactor for Q10-dependent respiratory chain enzymes · 200 mg Q10 + 200 µg Se combo reduced CV mortality 53% in elders 70+.
PQQ promotes mitochondrial biogenesis (creates new mitochondria) · Q10 loads existing · combo covers both pro-mitochondrial sides. Complementary synergy.
Q10 protects omega-3 from intracellular oxidation (PUFAs highly oxidizable). Cardio-protection combo, especially important in statin users (Q10 depletion + omega-3 need).
Carnitine transports fatty acids to mitochondrial matrix for β-oxidation · combo with Q10 (electron transport chain) covers all β-oxidation. Pro-mitochondrial stack athletes + HF.
8 real questions · literature-based answers.
Supplements · treatments · biomarkers for your complete protocol.
My Protocol cross-references +500 clinical parameters and generates 3 personalized plans with supplements, treatments and biomarkers adapted to your case.
Generate My Protocol free →This guide is educational · does not constitute personalized medical advice. Before supplementing, consult a healthcare professional. Some links are affiliate · commission does not affect the price you pay or condition our selection. No sponsorships. No advertorials.